Try our beta test site
Trial record 1 of 1 for:    VRC 602
Previous Study | Return to List | Next Study

Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB060-00-AB (VRC01), Administered Intravenously or Subcutaneously to Healthy Adults

This study has been completed.
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Institute of Allergy and Infectious Diseases (NIAID) ) Identifier:
First received: November 21, 2013
Last updated: January 24, 2017
Last verified: February 27, 2015